Showing results (91-100 of 453) with videos related to

Sort By:
Pageof 46
Journal of Hepatology|June 28, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
Expert Review of Clinical Pharmacology|September 11, 2018
The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugsCarlos Roncero, Jose Luis Villegas, Maria Martínez-Rebollar, et al.
Hepatology (Baltimore, Md.)|June 16, 2023
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints ConferenceMarc G Ghany, Maria Buti, Pietro Lampertico, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2021
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic ResponseZobair M Younossi, Andrei Racila, Andrew Muir, et al.
World Journal of Gastroenterology|April 16, 2019
Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfectionCristina Godoy, David Tabernero, Sara Sopena, et al.
Plos One|June 6, 2012
Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genomeFrancisco Rodriguez-Frías, David Tabernero, Josep Quer, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 yearsRafael Esteban, Raquel Domínguez-Hernández, Helena Cantero, et al.
JHEP Reports : Innovation in Hepatology|September 10, 2025
Clinical burden of HDV in Spain: Incidence, prevalence, and associated comorbiditiesMaria Buti, Nandita Kachru, Marvin Rock, et al.
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
Journal of Hepatology|February 10, 2021
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipientsMarkus Cornberg, Maria Buti, Christiane S Eberhardt, et al.
Pageof 46